Tumor-infiltrating lymphocyte therapy has received approval from FDA for some patients with metastatic melanoma.
New cell-based immunotherapy offered for melanoma (Links to an external site)

Tumor-infiltrating lymphocyte therapy has received approval from FDA for some patients with metastatic melanoma.
The Washington University campus community is making headlines every day. Members of the School of Medicine are regularly featured in local, national and international news stories. Department of Surgery faculty, staff and medical students are leaders in their specialties, and share their expertise when called upon.
The Skin Cancer Team at Washington University School of Medicine and Siteman Cancer Center shares information on skin cancer types and treatments.
The Skin Cancer Team at Washington University School of Medicine and Siteman Cancer Center shares their advice for safely enjoying outdoor activities.